Eskild Colding‐Jørgensen

604 total citations
14 papers, 461 citations indexed

About

Eskild Colding‐Jørgensen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Eskild Colding‐Jørgensen has authored 14 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eskild Colding‐Jørgensen's work include Genetic Neurodegenerative Diseases (7 papers), Ion channel regulation and function (6 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Eskild Colding‐Jørgensen is often cited by papers focused on Genetic Neurodegenerative Diseases (7 papers), Ion channel regulation and function (6 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Eskild Colding‐Jørgensen collaborates with scholars based in Denmark, United Kingdom and Norway. Eskild Colding‐Jørgensen's co-authors include David Wilkinson, Kristian Windfeld, John Vissing, Morten Dunø, Marianne Schwartz, Thomas Jespersen, Morten Grunnet, Martin Lauritzen, N. J. Johnsen and K. Særmark and has published in prestigious journals such as Neurology, The Lancet Neurology and Electroencephalography and Clinical Neurophysiology.

In The Last Decade

Eskild Colding‐Jørgensen

13 papers receiving 453 citations

Peers

Countries citing papers authored by Eskild Colding‐Jørgensen

Since Specialization

Citations

This map shows the geographic impact of Eskild Colding‐Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eskild Colding‐Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eskild Colding‐Jørgensen more than expected).

Fields of papers citing papers by Eskild Colding‐Jørgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eskild Colding‐Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eskild Colding‐Jørgensen. The network helps show where Eskild Colding‐Jørgensen may publish in the future.

Co-authorship network of co-authors of Eskild Colding‐Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Eskild Colding‐Jørgensen. A scholar is included among the top collaborators of Eskild Colding‐Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eskild Colding‐Jørgensen. Eskild Colding‐Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial 2014 ·The Lancet Neurology ·David Wilkinson, Kristian Windfeld, Eskild Colding‐Jørgensen	133
2	O3–06–01: A clinical phase II study of Lu AE58054 added to stable donepezil treatment in patients with moderate Alzheimer's disease 2013 ·Alzheimer s & Dementia ·David Wilkinson, Eskild Colding‐Jørgensen, Kristian Windfeld	8
3	Focal myositis of the thigh: report of two cases 2009 ·Acta Neurologica Scandinavica ·Eskild Colding‐Jørgensen, Henning Laursen, Martin Lauritzen	2
4	[Wartenberg's migrant sensory neuritis]. 2009 ·PubMed ·Eskild Colding‐Jørgensen	1
5	Phenotype and clinical course in a family with a new de novo Twinkle gene mutation 2008 ·Neuromuscular Disorders ·Tina D. Jeppesen, Marianne Schwartz, Eskild Colding‐Jørgensen, Thomas Krag, Simon Hauerslev, John Vissing	11
6	Autosomal dominant monosymptomatic myotonia permanens 2006 ·Neurology ·Eskild Colding‐Jørgensen, Morten Dunø, John Vissing	25
7	Phenotypic variability in myotonia congenita 2005 ·Muscle & Nerve ·Eskild Colding‐Jørgensen	115
8	Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype 2004 ·European Journal of Human Genetics ·Morten Dunø, Eskild Colding‐Jørgensen, Morten Grunnet, Thomas Jespersen, John Vissing, Marianne Schwartz	59
9	[Thomsen disease (myotonia congenita]. 2004 ·PubMed ·Eskild Colding‐Jørgensen	0
10	Decrement of compound muscle action potential is related to mutation type in myotonia congenita 2003 ·Muscle & Nerve ·Eskild Colding‐Jørgensen, Morten Dunø, Marianne Schwartz, John Vissing	31
11	Characterization of two new dominant ClC‐1 channel mutations associated with myotonia 2003 ·Muscle & Nerve ·Morten Grunnet, Thomas Jespersen, Eskild Colding‐Jørgensen, Marianne Schwartz, Dan A. Klærke, John Vissing, Søren‐Peter Olesen, Morten Dunø	16
12	Visual impairment in anti-GQ1b positive Miller Fisher syndrome 2001 ·Acta Neurologica Scandinavica ·Eskild Colding‐Jørgensen, John Vissing	20
13	Machado–Joseph disease in three Scandinavian families 1998 ·Journal of the Neurological Sciences ·(unknown), Jørgen E. Nielsen, Lis Hasholt, Kirsten Fenger, Lene Werdelin, Lisbeth Tranebjærg, Martin Lauritzen, Eskild Colding‐Jørgensen, (unknown), (unknown), S. A. Sørensen	16
14	On the evidence of auditory evoked magnetic fields as an objective measure of tinnitus 1992 ·Electroencephalography and Clinical Neurophysiology ·Eskild Colding‐Jørgensen, Martin Lauritzen, N. J. Johnsen, (unknown), K. Særmark	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact